Balyasny Asset Management »

Werewolf Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $644k 1.8M 0.36
2024-06-30 $26k 11k 2.44
2024-03-31 $149k 23k 6.48

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Select Sector Spdr Tr St Str Finl Etf Call Option (XLF)
Meta Platforms Cl A Call Option (META)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Warner Bros Discovery Com Ser A Call Option (WBD)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Microsoft Corporation Call Option (MSFT)
Tesla Motors Call Option (TSLA)

View all positions for Balyasny Asset Management

Top funds holding Werewolf Therapeutics

RA Capital Management
Balyasny Asset Management
Vanguard Capital Management
Renaissance Technologies
Lynx1 Capital Management
Sphera Funds Management
DC Funds
Verdad Advisers
Geode Capital Management
Bank of America Corporation
XTX Topco
Jane Street
UBS Group
Vanguard Fiduciary Trust
State Street Corporation

View all funds holding Werewolf Therapeutics